Literature DB >> 20821173

Sonographic visualization of the normal stomach: left lateral decubitus position.

Koichi Yabunaka1, Toshizo Katsuda, Shigeru Sanada, Hidetoshi Yatake, Kenyu Yamamoto.   

Abstract

The aim of this study was to evaluate the usefulness of an imaging technique that takes into account the effect of posture change on the stomach in transabdominal ultrasonography (US). A total of 240 adult patients (healthy subjects) underwent gastric US. In all subjects, the lesser curvature of the stomach (LCS) and left liver were measured in two different positions [left lateral decubitus (LLD) and supine]. The maximal length of the LCS was defined as the measured range between the cardial orifice and the left liver tip. The anteroposterior length (L1) and maximal longitudinal length (L2) of the left liver were determined on epigastric longitudinal scans. The mean LCS in the supine and LLD positions was 90.2 +/- 34.7 and 124.4 +/- 44.4 mm, respectively. The mean L1 in the supine and LLD positions was 54.0 +/- 12.7 and 65.6 +/- 14.4 mm, respectively. The mean L2 in the supine and LLD positions was 84.3 +/- 18.5 and 107.0 +/- 25.8 mm, respectively. The results for the measured LCS, L1, and L2 differed significantly between the supine and LLD positions (P < 0.05). This study demonstrated that the LCS could be clearly visualized on longitudinal scanning in the LLD position. Therefore, this position may potentially be more useful for gastric US, even in view of the limitations of this approach.

Entities:  

Mesh:

Year:  2007        PMID: 20821173     DOI: 10.1007/s12194-007-0018-6

Source DB:  PubMed          Journal:  Radiol Phys Technol        ISSN: 1865-0333


  15 in total

1.  Giant gastric folds: differential diagnosis at US.

Authors:  Hideharu Okanobu; Jiro Hata; Ken Haruma; Mutsuhiro Hara; Kenjiro Nakamura; Shinji Tanaka; Kazuaki Chayama
Journal:  Radiology       Date:  2003-01-24       Impact factor: 11.105

2.  Transabdominal ultrasonography in preoperative staging of gastric cancer.

Authors:  Sheng-Ri Liao; Ying Dai; Ling Huo; Kun Yan; Lin Zhang; Hui Zhang; Wen Gao; Min-Hua Chen
Journal:  World J Gastroenterol       Date:  2004-12-01       Impact factor: 5.742

3.  Site and size of bleeding peptic ulcer. Is there any relation to the efficacy of hemostatic sclerotherapy?

Authors:  E Brullet; R Campo; G Bedos; S Barcons; J M Gubern; J M Bordas
Journal:  Endoscopy       Date:  1991-03       Impact factor: 10.093

4.  In vivo hepatic volume determination using sonography and computed tomography. Validation and a comparison of the two techniques.

Authors:  D H Van Thiel; N G Hagler; R R Schade; M L Skolnick; A P Heyl; E Rosenblum; J S Gavaler; R J Penkrot
Journal:  Gastroenterology       Date:  1985-06       Impact factor: 22.682

5.  The location and size of gastric ulcers: radiologic and endoscopic evaluation.

Authors:  D W Gelfand; W J Dale; D J Ott
Journal:  AJR Am J Roentgenol       Date:  1984-10       Impact factor: 3.959

6.  Early gastric cancer: evaluation of diagnostic, clinicopathologic and therapeutic aspects in 60 cases.

Authors:  P Ribichini; E Piccinini; A Perrucci; V Stancanelli; G Fiorentini; R Campi; R Campagnoni
Journal:  Int Surg       Date:  1984 Oct-Dec

7.  Transabdominal sonography of gastroesophageal junctions.

Authors:  W Tanomkiat; P Chongchitnan
Journal:  J Clin Ultrasound       Date:  1999 Nov-Dec       Impact factor: 0.910

8.  Mechanical properties in the human gastric antrum using B-mode ultrasonography and antral distension.

Authors:  H Gregersen; O H Gilja; T Hausken; A Heimdal; C Gao; K Matre; S Ødegaard; A Berstad
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2002-08       Impact factor: 4.052

Review 9.  Imaging of the stomach and duodenum.

Authors:  C I Bartram
Journal:  Curr Opin Radiol       Date:  1991-06

10.  Clinicopathologic features of asymptomatic gastric adenocarcinoma patients in Korea.

Authors:  Seong-Ho Kong; Do Joong Park; Hyuk-Joon Lee; Hyun Chae Jung; Kuhn Uk Lee; Kuk Jin Choe; Han-Kwang Yang
Journal:  Jpn J Clin Oncol       Date:  2004-01       Impact factor: 3.019

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.